QUALITY OF LIFE IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS IN THE CONDITIONS OF TREATMENT WITH CHIMERIC MONOCLONAL ANTIBODIES TO TNF α
The article presents results of study of inhibitor TNF α — infliximab — on quality of life in patients with juvenile arthritis, refractory to standard immunosuppressive treatment. In 1.5 months after the beginning of treatment, the quality of life increased in 98% of patients; and in one year, the r...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2009-05-01
|
| Series: | Вопросы современной педиатрии |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/1113 |
| _version_ | 1797696804361338880 |
|---|---|
| author | R.V. Denisova E.I. Alexeeva V.Yu. Al'bitsky I.V. Vinyarskaya S.I. Valieva |
| author_facet | R.V. Denisova E.I. Alexeeva V.Yu. Al'bitsky I.V. Vinyarskaya S.I. Valieva |
| author_sort | R.V. Denisova |
| collection | DOAJ |
| description | The article presents results of study of inhibitor TNF α — infliximab — on quality of life in patients with juvenile arthritis, refractory to standard immunosuppressive treatment. In 1.5 months after the beginning of treatment, the quality of life increased in 98% of patients; and in one year, the rates of physical functioning were similar to it in healthy children the same age.Key words: children, juvenile arthritis, quality of life, infliximab.(Voprosy sovremennoi pediatrii — Current Pediatrics. 2009;8(3):18-26) |
| first_indexed | 2024-03-12T03:31:26Z |
| format | Article |
| id | doaj.art-037987f8fb3f4eeb96ecc259a8c562c7 |
| institution | Directory Open Access Journal |
| issn | 1682-5527 1682-5535 |
| language | English |
| last_indexed | 2024-03-12T03:31:26Z |
| publishDate | 2009-05-01 |
| publisher | "Paediatrician" Publishers LLC |
| record_format | Article |
| series | Вопросы современной педиатрии |
| spelling | doaj.art-037987f8fb3f4eeb96ecc259a8c562c72023-09-03T13:24:32Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352009-05-018318261114QUALITY OF LIFE IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS IN THE CONDITIONS OF TREATMENT WITH CHIMERIC MONOCLONAL ANTIBODIES TO TNF αR.V. Denisova0E.I. Alexeeva1V.Yu. Al'bitsky2I.V. Vinyarskaya3S.I. Valieva4Научный центр здоровья детей РАМН, МоскваНаучный центр здоровья детей РАМН, МоскваНаучный центр здоровья детей РАМН, МоскваScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowНаучный центр здоровья детей РАМН, МоскваThe article presents results of study of inhibitor TNF α — infliximab — on quality of life in patients with juvenile arthritis, refractory to standard immunosuppressive treatment. In 1.5 months after the beginning of treatment, the quality of life increased in 98% of patients; and in one year, the rates of physical functioning were similar to it in healthy children the same age.Key words: children, juvenile arthritis, quality of life, infliximab.(Voprosy sovremennoi pediatrii — Current Pediatrics. 2009;8(3):18-26)https://vsp.spr-journal.ru/jour/article/view/1113 |
| spellingShingle | R.V. Denisova E.I. Alexeeva V.Yu. Al'bitsky I.V. Vinyarskaya S.I. Valieva QUALITY OF LIFE IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS IN THE CONDITIONS OF TREATMENT WITH CHIMERIC MONOCLONAL ANTIBODIES TO TNF α Вопросы современной педиатрии |
| title | QUALITY OF LIFE IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS IN THE CONDITIONS OF TREATMENT WITH CHIMERIC MONOCLONAL ANTIBODIES TO TNF α |
| title_full | QUALITY OF LIFE IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS IN THE CONDITIONS OF TREATMENT WITH CHIMERIC MONOCLONAL ANTIBODIES TO TNF α |
| title_fullStr | QUALITY OF LIFE IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS IN THE CONDITIONS OF TREATMENT WITH CHIMERIC MONOCLONAL ANTIBODIES TO TNF α |
| title_full_unstemmed | QUALITY OF LIFE IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS IN THE CONDITIONS OF TREATMENT WITH CHIMERIC MONOCLONAL ANTIBODIES TO TNF α |
| title_short | QUALITY OF LIFE IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS IN THE CONDITIONS OF TREATMENT WITH CHIMERIC MONOCLONAL ANTIBODIES TO TNF α |
| title_sort | quality of life in patients with juvenile rheumatoid arthritis in the conditions of treatment with chimeric monoclonal antibodies to tnf α |
| url | https://vsp.spr-journal.ru/jour/article/view/1113 |
| work_keys_str_mv | AT rvdenisova qualityoflifeinpatientswithjuvenilerheumatoidarthritisintheconditionsoftreatmentwithchimericmonoclonalantibodiestotnfa AT eialexeeva qualityoflifeinpatientswithjuvenilerheumatoidarthritisintheconditionsoftreatmentwithchimericmonoclonalantibodiestotnfa AT vyualbitsky qualityoflifeinpatientswithjuvenilerheumatoidarthritisintheconditionsoftreatmentwithchimericmonoclonalantibodiestotnfa AT ivvinyarskaya qualityoflifeinpatientswithjuvenilerheumatoidarthritisintheconditionsoftreatmentwithchimericmonoclonalantibodiestotnfa AT sivalieva qualityoflifeinpatientswithjuvenilerheumatoidarthritisintheconditionsoftreatmentwithchimericmonoclonalantibodiestotnfa |